Mint Medical is on the front lines in the fight against COVID-19, proving that radiology can act as a role model for gathering evidence by utilizing structured data.
In this webcast, Prof. Dr. Maria-Katharina Ganten and Gabriel Salg highlight the urgent need for structured data collection, as well as the importance of data quality, integrity, and traceability. The hosts discuss how to support trial compatible data acquisition in routine work by example of a European multicenter project.
Prof. Ganten and Mr. Salg also provide a look to the future in which radiology has the opportunity to set standards for new research strategies, not only concerning COVID studies but rather for any disease or treatment.
-
37 minute(s)
Clinical trial excellence for routine covid-19 assessment
Related Resources
Integrated Data Management for Multicentric Imaging in Investigator-Initiated Trials (IITs)
Establishing a Framework for Multicentric Data Coordination
For many investigators, the transition from a single-site study to a multicentric model…
Bridging the Gap Between RECIST and Survival: Why the FDA’s Analysis of the g Value is a Game-Changer
For decades, oncology trials have relied on RECIST 1.1 to evaluate drug efficacy. However, these categorical "snapshot" evaluations do not always…
RACOON – Imaging, Data & Collaboration for Better Decisions
Modern radiology faces a central question: how can imaging and clinical data be combined in a way that leads to more precise diagnoses,…